Skip to main content

Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study.

Publication ,  Journal Article
Eghrari, AO; Shantha, JG; Ross, RD; Ryn, CV; Crozier, I; Hayek, B; Gradin, D; Roberts, B; Prakalapakorn, SG; Amegashie, F; Nishant, K; Dolo, R ...
Published in: Transl Vis Sci Technol
January 2021

PURPOSE: In survivors of Ebola virus disease (EVD), intraocular viral persistence raises questions about the timing and safety of cataract surgery. To the best of our knowledge, this is the first controlled study evaluating Ebola virus persistence and cataract surgery safety and outcomes in EVD survivors. METHODS: Seropositive EVD survivors and seronegative controls with vision worse than 20/40 from cataract and without active intraocular inflammation were enrolled. Aqueous humor from survivors was tested with reverse transcription-polymerase chain reaction for Ebola viral RNA. Participants underwent manual small-incision cataract surgery and 1 year of follow-up examinations. RESULTS: Twenty-two eyes of 22 survivors and 12 eyes of eight controls underwent cataract surgery. All of the aqueous samples tested negative for Ebola viral RNA. Median visual acuity improved from 20/200 at baseline to 20/25 at 1 year in survivors and from count fingers to 20/50 in controls (overall, P < 0.001; between groups, P = 0.07). After a 1-month course of topical corticosteroids, 55% of survivors and 67% of controls demonstrated at least 1+ anterior chamber cell. Twelve months after surgery, optical coherence tomography revealed a median increase in macular central subfield thickness of 42 µm compared with baseline (overall, P = 0.029; between groups, P = 0.995). CONCLUSIONS: EVD survivors and controls demonstrated significant visual improvement from cataract surgery. The persistence of intraocular inflammation highlights the importance of follow-up. The absence of detectable intraocular Ebola viral RNA provides guidance regarding the safety of eye surgery in Ebola survivors. TRANSLATIONAL RELEVANCE: These findings demonstrate the safety and efficacy of cataract surgery in Ebola survivors and will inform ocular surgery guidelines in this population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Transl Vis Sci Technol

DOI

EISSN

2164-2591

Publication Date

January 2021

Volume

10

Issue

1

Start / End Page

32

Location

United States

Related Subject Headings

  • Survivors
  • Humans
  • Hemorrhagic Fever, Ebola
  • Ebolavirus
  • Cataract Extraction
  • Cataract
  • 3212 Ophthalmology and optometry
  • 1113 Opthalmology and Optometry
  • 0903 Biomedical Engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Eghrari, A. O., Shantha, J. G., Ross, R. D., Ryn, C. V., Crozier, I., Hayek, B., … Bishop, R. J. (2021). Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study. Transl Vis Sci Technol, 10(1), 32. https://doi.org/10.1167/tvst.10.1.32
Eghrari, Allen O., Jessica G. Shantha, Robin D. Ross, Collin Van Ryn, Ian Crozier, Brent Hayek, Dan Gradin, et al. “Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study.Transl Vis Sci Technol 10, no. 1 (January 2021): 32. https://doi.org/10.1167/tvst.10.1.32.
Eghrari AO, Shantha JG, Ross RD, Ryn CV, Crozier I, Hayek B, et al. Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study. Transl Vis Sci Technol. 2021 Jan;10(1):32.
Eghrari, Allen O., et al. “Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study.Transl Vis Sci Technol, vol. 10, no. 1, Jan. 2021, p. 32. Pubmed, doi:10.1167/tvst.10.1.32.
Eghrari AO, Shantha JG, Ross RD, Ryn CV, Crozier I, Hayek B, Gradin D, Roberts B, Prakalapakorn SG, Amegashie F, Nishant K, Singh G, Dolo R, Fankhauser J, Burkholder B, Pettitt J, Gross R, Brady T, Dighero-Kemp B, Reilly C, Hensley L, Higgs E, Yeh S, Bishop RJ. Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study. Transl Vis Sci Technol. 2021 Jan;10(1):32.

Published In

Transl Vis Sci Technol

DOI

EISSN

2164-2591

Publication Date

January 2021

Volume

10

Issue

1

Start / End Page

32

Location

United States

Related Subject Headings

  • Survivors
  • Humans
  • Hemorrhagic Fever, Ebola
  • Ebolavirus
  • Cataract Extraction
  • Cataract
  • 3212 Ophthalmology and optometry
  • 1113 Opthalmology and Optometry
  • 0903 Biomedical Engineering